Thu, March 10, 2022

Joseph Catanzaro Maintained (SNSE) at Buy with Decreased Target to $10 on, Mar 10th, 2022

Joseph Catanzaro of Piper Sandler, Maintained "Sensei Biotherapeutics, Inc." (SNSE) at Buy with Decreased Target from $12 to $10 on, Mar 10th, 2022.

Joseph, nor any peers, have made any analyst calls on SNSE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30